2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Prostate Cancer Screening
Prostate cancer screening is a critical aspect of cancer research, aimed at early detection and intervention for one of the most common cancers affecting men. Screening methods include the prostate-specific antigen (PSA) blood test and digital rectal exam (DRE). However, debate surrounds the effectiveness of routine screening due to concerns about overdiagnosis and overtreatment. While early detection can lead to timely treatment, it may also result in unnecessary interventions for slow-growing tumors. Researchers are exploring novel approaches like advanced imaging techniques and biomarker tests to improve screening accuracy and minimize harm. Personalized screening strategies based on individual risk factors are also gaining attention to optimize outcomes while reducing unnecessary procedures. Balancing the benefits and risks of prostate cancer screening remains a pivotal focus in cancer research to enhance early detection and treatment efficacy while minimizing adverse effects.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China